US$ 20.87
glp-1 testosterone Study Shows Medications Could Boost Male Levels and Sperm Count GLP-1 drugs linked to boosting
Description
The REWIND trial investigated the cardiovascular benefits of dulaglutide, a GLP-1 receptor agonist, in a population of 9,901 patients with T2DM aged 50+ and either established CVD or risk factors
Evans AJ, Krentz AJ

J., Warden M

Our dedicated team of healthcare professionals is here to provide personalized support and comprehensive care tailored to your needs

Yu YC, Cao LH, Yang XL
